BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Feb 21, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Results

LaViv azficel-T: Pilot trial data

An open-label, U.S. pilot trial in 5 patients with vocal fold scarring showed that 3 doses of laViv injected into the superficial lamina propria layer of the vocal folds at 4-week intervals met the primary endpoint of significantly improving mucosal wave grade from baseline to...

Read the full 203 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >